Carregant...

The pharmacokinetics of doxazosin in patients with hypertension and renal impairment.

1. The pharmacokinetics of doxazosin, following a single oral dose (1 mg) and chronic oral dosing (doubling doses up to a maximum of 16 mg day-1), were studied in 18 patients with mild to moderate hypertension and stable renal function varying from normal to severely impaired. In addition, the effec...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Oliver, R M, Upward, J W, Dewhurst, A G, Honeywell, R, Renwick, A G, Waller, D G
Format: Artigo
Idioma:Inglês
Publicat: 1990
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1380111/
https://ncbi.nlm.nih.gov/pubmed/2139337
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!